Anthelmintics as Potential Anti-Cancer Drugs?

被引：3
|
作者：
Heo, Dae Seog [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF KOREAN MEDICAL SCIENCE | 2020年 / 35卷 / 06期
关键词：
D O I：
10.3346/jkms.2020.35.e75
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] FORMULATION OF INVESTIGATIONAL ANTI-CANCER DRUGS
    REPTA, AJ
    PHARMACY INTERNATIONAL, 1981, 2 (07): : ABS2 - ABS2
  • [42] EFFECT OF ANTI-CANCER DRUGS ON COMPLEMENT
    MCKENZIE, D
    CLOSKY, J
    HETRICK, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 54 - &
  • [43] THE RISING COST OF ANTI-CANCER DRUGS
    Karikios, D. J.
    Schofield, D.
    Salkeld, G.
    Mann, K. P.
    Trotman, J.
    Stockler, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E35 - E35
  • [44] Is the Price of Anti-Cancer Drugs Justified?
    Guillot, B.
    ONCOLOGIE, 2017, 19 (11-12) : 381 - 385
  • [45] Developing New Anti-Cancer Drugs
    Pereira, Ricardo de Souza
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (01) : 1 - 5
  • [46] Anti-Cancer Drugs: The mitochondrial paradox
    Penman, Sophie L.
    Jensen, Rebecca L.
    Kiy, Robyn T.
    Chadwick, Amy E.
    ELIFE, 2020, 9
  • [47] APPROACHES TO EFFECTIVE ANTI-CANCER DRUGS
    NEIDLE, S
    NATURE, 1977, 268 (5617) : 195 - 196
  • [48] Intrinsically Fluorescent Anti-Cancer Drugs
    Kabir, Md Lutful
    Wang, Feng
    Clayton, Andrew H. A.
    BIOLOGY-BASEL, 2022, 11 (08):
  • [49] ACCESS TO EXPENSIVE ANTI-CANCER DRUGS
    Sullivan, Danny
    Mileshkin, Linda
    JOURNAL OF LAW AND MEDICINE, 2011, 19 (02) : 232 - 243
  • [50] Phosphodiesterase inhibitors as anti-cancer drugs
    Hirsh, L
    Dantes, A
    Suh, BS
    Yoshida, Y
    Hosokawa, K
    Tajima, K
    Kotsuji, F
    Merimsky, O
    Amsterdam, A
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 981 - 988
12345